期刊文献+

溶基质素1基因启动子区5A/6A多态性与中国北方人群脑血栓形成发病无关

5A/6A Polymorphism in the Promoter of Stromelysin-1 Gene Is Not Associated with Cerebral Thrombosis in Northern Chinese Population
下载PDF
导出
摘要 为了解溶基质素 1基因启动子区 5A 6A多态性与脑血栓形成之间的关系 ,利用聚合酶链反应和分子杂交技术对该多态性在中国北方人群脑血栓患者 (112 2例 )中的分布进行检测和分析 ,并与无脑血管病变的人群 (112 3例 )进行比较。结果发现 ,5A 6A多态性在两组人群中的分布符合Hardy Weinberg遗传平衡定律 ,脑血栓患者中5A5A、5A6A、6A6A三种基因型频率分别为 2 .5 0 %、2 7.6 3%和 6 9.88% ,对照组分别为 2 .2 3%、2 6 .18%和 71.5 9% ;两组人群 5A等位基因频率分别为 16 .31%和 15 .32 % ,均无统计学差异 (P >0 .0 5 )。结果提示 ,溶基质素 1基因启动子区 5A 6A多态性不是中国人群脑血栓形成发病的遗传学标记物。 Aim To evaluate the relationship between 5A/6A polymorphism in the promoter of stromelysin-1 gene and cerebral thrombosis in Chinese population. Methods The stromelysin-1 promoter 5A/6A polymorphism in 1 122 patients with cerebral thrombosis and 1 123 controls were screened by polymerase chain reaction (PCR), and then corresponding probe hybridization was performed. Results The distribution of 5A/6A polymorphism was in agreement with Hardy-Weinberg Equilibrium in both patients and controls. The prevalence of 5A5A, 5A6A and 6A6A genotypes were 2.50%, 27.63% and 69.88% in patients, and 2.23%, 26.18% 71.59% in controls, respectively. No significant difference was observed between these two groups (P>0.05). The 5A allele frequencies were 16.31% in patients, and 15.32% in controls. There is no dramatic distinction between cases and controls, either (P>0.05). Conclusion 5A/6A polymorphism in the promoter of stromelysin-1 gene is not a genetic marker of cerebral thrombosis in Chinese population.
出处 《中国动脉硬化杂志》 CAS CSCD 2004年第6期716-718,共3页 Chinese Journal of Arteriosclerosis
关键词 流行病学 溶基质素1基因启动子区5A/6A多态性与脑血栓形成发病无关 聚合酶链反应 溶基质素1 启动子 基因多态性 脑血栓形成 Stromelysin-1 Promoter Gene Polymorphism Cerebral Thrombosis Allele Frequencies Genotypes
  • 相关文献

参考文献10

  • 1周定标.积极开展缺血性脑血管病的外科治疗[J].中华神经外科杂志,1999,15(3):129-130. 被引量:18
  • 2任艳,唐力,聂迎雪,宋平梅,任卫东.颈动脉粥样硬化与短暂性脑缺血发作的相关性[J].中国动脉硬化杂志,2003,11(1):63-65. 被引量:71
  • 3[3]Rauramaa R, V aisanen SB, Luong LA, Schmidt-Trucksass A, Pentti1a IM, Bouchard C, et al. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Artenoscler Thromb Vasc Biol, 2000, 20 (12): 2 657-662
  • 4[4]Saus J, Quinones S, Otani Y, Nagase H, Harris ED Jr, Kurkinen, M. The complete primary structure of human matrix metalloproteinase-3 Identity with stromelysin. J Biol Chem, 1988, 263 (14): 6 742-745
  • 5于滢,杨向红.基质金属蛋白酶与动脉粥样硬化及斑块破裂的关系[J].中国动脉硬化杂志,2003,11(6):592-595. 被引量:38
  • 6[6]Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM.Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression.J Biol Chem, 1996, 271 (22): 13055-060
  • 7[7]Medley TL, Kingwell BA, Gatzka CD, Pillay P, Cole TJ. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ Res, 2003,92(11): 1 254-261
  • 8[8]Ghilardi G, Biondi ML, DeMonti M, Turri O, Guagnellini E, Scorza R. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke, 2002, 33 (10): 2 408-412
  • 9[9]Rundek T, Elkind MS, Pittman J, Boden-Albala B, Martin S, Humphries SE, et al. Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke, 2002, 33 (5): 1 420-423
  • 10[10]Beyzade S, Zhang S, Wong YK, Day IN, Eriksson P, Ye S. Influences of matrix metalloproteinase-3 gene variation on extent of coronary athersclerosis and risk of myocardial infarction. J Am Coll Cardiol, 2003, 41 (12): 213-137

二级参考文献46

  • 1[1]Turkenburg JL, Oostayen JA, Bollen WL. Role of carotid sonography as a first examination in the evaluation of patients with transient ischemic attacks and strokes:benefit in relation to age. J Clin Ultrasound, 1999, 27 (2): 65-69
  • 2[2]Sterpetti AV, Schultz RD, Feldhaus RJ, Davenport KL, Richardson M, Farina C. Ultrasonographic features of carotid plaque and the risk of subsequent neurologic deficits. Surgery, 1988, 104 (4): 652-660
  • 3[3]Oholleran LW, Kennelly MM, Mcclurken M, Johnson M. Natural history of asymptomatic carotid plaque. Am J Surg, 1987, 154 (6): 659-662
  • 4[5]Aburahma AF, Kyer PD, Robinson PA, Honnay RS. The correlation of ultrasonic carotid plaque morphology and carotid plaque hemorrhage. Clinical implications. Surgery, 1998, 124 (4): 721-728
  • 5[6]Grohddt ML. Ultrasound and lipoproteins as predictors of lipid-rich rupture-prone plaques in the carotid artery. Arterioscler Thromb Vasc Biol, 1999, 19 (2): 2-13
  • 6[7]Rothwell PM, GibsonR, Warlow CP. Interrelation between plaque surface morphology and degree of stenosis on carotid angiograms and the risk of ischemic stroke in patients with symptomatic carotid stenosis. Stroke, 2000, 31 (3): 615-621
  • 7[1]Matrisian LM. Metalloproteinases and their inhibitors in matrix remodelling. Trends Genetics, 1990, 6: 121-125
  • 8[2]Murphy G, Stanton H, Cowell S, et al. Mechanisms for pro matrix metalloproteinase activation. APMIS, 1999, 107: 38-44
  • 9[3]Alexander CM, Werb Z. Extracellular matrix degradation. In: Hay ED, ed. Cell biology of extracellular matrix. New York: Plenum Press, 1991, 255-302
  • 10[4]Birkedal-Hansen H, Moore WGl, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med, 1993, 4: 197-250

共引文献124

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部